Nest Genomics
PrivateLast Round
Seed
Jan 10, 2023
Total Funding Raised
$9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nest Genomics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in January 2023.
Nest Genomics is a health technology company that provides a software platform for healthcare organizations to integrate and scale genomic programs.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, EHR & EMR, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nest Genomics Comparables
Compare Nest Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhenoTips | 83% | |
| Arboretum LifeSciences | 81% | |
| Genetics Adviser | 77% |
For institutional investors. Book with your work email.
Nest Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 10, 2023 | ||||
| Accelerator | Mar 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nest Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| B Capital Group | Seed |
| Samsung Next TLV | Seed |
| Y Combinator | Seed, Accelerator |
| Arkin Digital Health | Seed |
| Maven Ventures | Seed |
| Casdin Capital | Seed |
| iAngels | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 118% MoM, reaching 8K.
- Feb 1, 2026
Added Mychartatradychildrens, an enterprise healthcare company, as a customer.
For institutional investors. Book with your work email.
Nest Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nest Genomics's valuation, stock price, and market status.
Is Nest Genomics a public or private company?
Nest Genomics is a private company.
What is the current stock price of Nest Genomics?
Nest Genomics is a private company, so its shares have no public market price. Caplight tracks Nest Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nest Genomics worth (valuation)?
Valuation information for Nest Genomics is not publicly available.
Can I buy Nest Genomics stock?
Nest Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nest Genomics's last funding round?
Nest Genomics's most recent funding round was Seed on January 10, 2023.
Who are the main investors in Nest Genomics?
Key investors in Nest Genomics include B Capital Group, Y Combinator.
Will Nest Genomics IPO soon?
No public IPO plans have been announced for Nest Genomics.
How can I track Nest Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Nest Genomics's shares on secondary markets.